A view shows the headquarters of Life Technologies Corp in Carlsbad, California April 15, 2013. REUTERS/Mike Blake

The conditions are that Thermo Fisher cut the prices of two types of its products sold in China, sell its cell culture and gene adjustment businesses, and its stake of 51 percent in China’s Lanzhou National Hyclone Bio-engineering Co Ltd.